Number Т. 9, № 4 (36) 2019

Author :   Filonenko K.S.

Quality of life level in patients with diffuse large B-cell lymphoma from high-risk group treated with R-DA-EPOCH regimen
Authors: Filonenko K.S. Kriachok I.A. Stepanishyna Y.A. Martynchyk A.... №4(28) 2017 / Review: 2
Immunohistochemical c-MYC expression in different subtypes of diffuse large B-cell lymphoma
Authors: Kriachok I.A. Martynchyk A. Filonenko K.S. Stepanishyna Y.A.... №4(28) 2017 / Review: 248
MALT-lymphoma: etiology, pathogenesis, classification, clinical issues
Authors: Kriachok I.A. Ulianchenko K.O. Kadnikova T. Tytorenko I.... №1(25) 2017 / Review: 20227
Central nervous system involvement prophylaxis in patients with diffuse large B-cell lymphoma
Authors: Kriachok I.A. Filonenko K.S. Kuschevyy E. №3(23) 2016 / Review: 1761
Blocking PD-1/PD-L1/2 way — promising treatment strategy of patients with B-cell lymphomas (review)
Authors: Kriachok I.A. Novosad I.O. Khranovskaya N.M. Svеrgun N.N.... №1(17) 2015 / Review: 1
The methods of fertility preservation in women with lymphoproliferative diseases
Authors: Kriachok I.A. Kadnikova T. Tytorenko I. Pastushenko J.... №4(16) 2014 / Review: 891
Cytomegalovirus infection in hematology and oncology patients receiving cytotoxic therapy (review and case report)
Authors: Kuschevyy E. Kriachok I.A. Stepanishyna Y.A. Martynchyk A.... №2(10) 2013 / Review: 10221
Treatment and prevention of toxic phlebitis induced by chemotherapy in patients with breast cancer
Authors: Sivak L.A. Gubаrеvа А.А. Lyalkin S.A. Mаydаnеvich N.N.... №1(9) 2013 / Review: 822
Biological factors of Hodgkin’s lymphoma prognosis (review)
Authors: Svеrgun N.N. Khranovskaya N.M. Kriachok I.A. Novosad I.O.... №6 (2) 2012 / Review: 1
Therapy efficacy in patients with Non-Hodgkin’s Lymphomas with rituximab
Authors: Kriachok I.A. Filonenko K.S. Gubаrеvа А.А. Tytorenko I.... №3 (3) 2011 / Review: 9644